Rigel Pharmaceuticals RIGL is scheduled to report third-quarter 2025 results on Nov. 4, after market close. The Zacks ...

Rigel Pharmaceuticals has landed on CNBC's list of top performing stocks of companies located in San Francisco.

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its third quarter 2025 financial results after ...

Rigel Pharmaceuticals RIGL will release its quarterly earnings report on Tuesday, 2025-08-05. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Rigel Pharmaceuticals ...

A substantial acquisition of company stock options by RAUL RODRIGUEZ, CEO at Rigel Pharmaceuticals (NASDAQ:RIGL) was reported on September 17, based on a new SEC filing. What Happened: In a Form 4 ...

XTX Topco Ltd bought a new stake in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission.

Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Get Free Report) have received a consensus recommendation of “Hold” from the five analysts that are currently covering the stock, Marketbeat.com ...

SOUTH SAN FRANCISCO, Calif., April 4, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. ("Rigel") (Nasdaq: RIGL) today announced that it has granted awards pursuant to the Rigel Pharmaceuticals, Inc.

Shares of Rigel Pharmaceuticals (RIGL) have been strong performers lately, with the stock up 56.6% over the past month. The stock hit a new 52-week high of $30.43 in the previous session. Rigel has ...

Rigel Pharmaceuticals, Inc. shows strong momentum, with a 68% YoY revenue increase, driven by TAVALISSE, GAVRETO, and REZLIDHIA, suggesting a shift to a durable growth stock. Q1 net income of $11.4M ...